Laura Bessen
Direttore/Membro del Consiglio presso C4 THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Laura Bessen is an Independent Director at C4 Therapeutics, Inc. and Artiva Biotherapeutics, Inc. She previously worked as the Vice President & Head-US Medical at Bristol Myers Squibb Co. Dr. Bessen holds an undergraduate degree from the State University of New York at Binghamton and a doctorate degree from New York University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
-.--% | 23/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Laura Bessen
| Società | Posizione | Inizio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 29/07/2022 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 03/03/2022 |
Precedenti posizioni note di Laura Bessen
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2016 |
Formazione di Laura Bessen
| New York University School of Medicine | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| C4 THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Laura Bessen
